In an article by Shroder et al published in Europe Urol (2012), the authors publish results from the European randomised study of screening for prostate cancer. They report that screening significantly reduces the risk of developing metastatic disease in the 76813 men with available data. At 12 years follow up 256 screened men and 410 control men had developed metastasis. This was a relative risk reduction of 30% or 3.1 per 1000 men randomised (42% in the intention to screen analysis).
Screening for prostate cancer using the PSA blood test remains amongst the most controversial subject in Urology, but this data adds significantly to the body of evidence supporting screening.
Everything is very open with a really clear explanation of the challenges. It was definitely informative. Your website is extremely helpful. Thanks for sharing!
Lots of the commments on this weblog demonstrate that there is complete ignorance about these things
Oh my goodness! Amazing article dude! Thank you so much, However I am having difficulties with your RSS. I don’t know why I cannot subscribe to it. Is there anybody else having similar RSS issues? Anyone that knows the answer will you kindly respond? Thanks!!
Way cool! Some extremely valid points! I appreciate you penning this write-up plus the rest of the website is also really good.
I discovered your blog using google. I must I am floored by your blog. Keep up the good work.
Excellently written article, doubts all bloggers
offered that the same content because you, that the
internet is a greater place. Please keep it up!